High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.
By Stephanie J. Lee, John P. Klein, M. Haagenson, L. Baxter‐Lowe, D. Confer, M. Eapen, M. Fernández-Viña, N. Flomenberg, M. Horowitz, C. Hurley and 8 more. Blood, 2007
1,248 citations recorded by the source corpus.
Subfields: Hematology, Immunology
View Paper: https://www.semanticscholar.org/paper/5d979a7b4b61675402b306406e95d7db57caed13
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Immunology
Citations in the corpus
- The IMGT/HLA database (2008, background): “HLA alleles can have a critical impact on the outcome of a haematopoietic stem cell transplant (22,23).”
- Reduced mortality after allogeneic hematopoietic cell transplantation (2010, neutral): “Chronic myeloid leukemia 463 (33) 104 (9)”
- The IPD and IMGT/HLA database: allele variant databases (2014, background): “HSCT uses DNA sequences to identify potential transplant donors with patients, as HLA matching is a critical factor when considering potential donors for patients receiving allogeneic transplants for haematological disorders (4,7).”
- Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet. (2013, background): “However, in recent years, high-resolution donor-recipient HLA matching has significantly improved the outcome of this procedure.(138) In a prospective study from the French Society of Bone Marrow Transplantation and Cell Therapy comparing the outcome of allogeneic marrow SCT from HLA-identical sibli”
- Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia. (2010, positive): “NK cells are the first lymphocyte population to expand after HCT and engraftment with alloreactive NK cells has many potential benefits, including (1) decreased rates of GVHD,39 (2) decreased rates of graft rejection mediated by NK lysis of host T cells, (3) decreased relapse,40 (4) improved engraft”